Editas Medicine, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Editas Medicine, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q2 2024.
  • Editas Medicine, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.01M, a 3.93% decline year-over-year.
  • Editas Medicine, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $22.7M, a 8.13% increase year-over-year.
  • Editas Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19.8M, a 32.4% decline from 2022.
  • Editas Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $29.3M, a 32.5% decline from 2021.
  • Editas Medicine, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $43.4M, a 87.4% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $22.7M $5.01M -$205K -3.93% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $22.9M $7.59M +$3.08M +68.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $19.8M $5.35M -$19K -0.35% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 $19.8M $4.73M -$1.15M -19.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $21M $5.22M -$1.4M -21.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $22.4M $4.51M -$6.92M -60.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $29.3M $5.36M -$2.29M -29.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 $31.6M $5.88M -$4.13M -41.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $35.7M $6.62M -$6.91M -51.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $42.6M $11.4M -$773K -6.33% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $43.4M $7.66M +$1.98M +35% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-22
Q3 2021 $41.4M $10M +$4.17M +71.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 $37.2M $13.5M +$8.11M +150% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $29.1M $12.2M +$5.98M +96.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 $23.2M $5.67M -$663K -10.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $23.8M $5.85M -$713K -10.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $24.5M $5.42M -$1.08M -16.6% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $25.6M $6.22M -$1.64M -20.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $27.2M $6.34M -$11K -0.17% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-26
Q3 2019 $27.3M $6.56M -$140K -2.09% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $27.4M $6.49M -$531K -7.56% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $27.9M $7.86M +$1.33M +20.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $26.6M $6.35M -$1.74M -21.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 $28.3M $6.7M +$2.23M +49.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $26.1M $7.02M +$2.01M +40% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 $24.1M $6.53M +$724K +12.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 $23.4M $8.09M +$4.3M +114% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-26
Q3 2017 $19.1M $4.47M +$777K +21.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $18.3M $5.02M -$181K -3.48% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 $18.5M $5.8M +$1.59M +37.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $16.9M $3.78M +$1.83M +93.9% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-01
Q3 2016 $15M $3.69M +$2.63M +249% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $12.4M $5.2M +$4.76M +1081% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $7.66M $4.21M +$4.15M +6377% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 $3.51M $1.95M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 $1.06M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $440K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $65K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.